Tender detail
Medicinal products with active substance Ravulizumab
Summary
The tender concerns the supply of medicinal products containing Ravulizumab; it is conducted as an open procurement, and the awarding criterion is price, the sole criterion.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.